Skip to main content
. Author manuscript; available in PMC: 2014 Sep 22.
Published in final edited form as: Urology. 2011 Dec 14;79(2):361–364. doi: 10.1016/j.urology.2011.04.050

Table 1.

Summary of baseline features for 255 patients treated with primary RPLND for NSGCT.

Feature Median IQR

Age 30 23–37

BMI 26 23–29

Total node count 38 27–53
Feature No. %

Primary Histology
 Mixed 210 82.4
 Pure Embryonal 41 16.0
 Pure Teratoma 3 1.2
 Pure Malignant Transformation 1 0.4

Clinical Stage
 IA 26 10
 IB 147 58
 IIA 82 32

pN Stage
 N0 180 70
 N1 50 20
 N2 25 10

RPLND Histology
 Benign 180 70
 Viable GCT (only) 56 22
 Viable GCT and Teratoma 10 4
 Teratoma (only) 9 4